ASH 2021 Conference Coverage on VuMedi
ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negativity in NDMM Patients Treated with D-KRd
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eileen Boyle
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eileen Boyle
Login to view comments.
Click here to Login
